Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 2/20 | 0.50 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21925246 | 0.97 | TRIM24 (0.53) | TRIM24TRIM33ALDH1A1CRBNCA1 | |
| SCHEMBL21925266 | 0.97 | TRIM24 (0.53) | TRIM24TRIM33ALDH1A1CRBNCA1 | |
| SCHEMBL1655400 | 0.97 | TRIM24 (0.53) | TRIM24TRIM33ALDH1A1CRBNCA1 | |
| SCHEMBL727114 | 0.97 | TRIM24 (0.53) | TRIM24TRIM33ALDH1A1CRBNCA1 | |
| SCHEMBL22320959 | 0.97 | TRIM24 (0.53) | TRIM24TRIM33ALDH1A1CRBNCA1 | |
| SCHEMBL1655628 | 0.97 | TRIM24 (0.53) | TRIM24TRIM33ALDH1A1CRBNCA1 | |
| SCHEMBL105656 | 0.87 | — | — | |
| SCHEMBL14066006 | 0.87 | — | — | |
| SCHEMBL2046507 | 0.86 | TRIM24 (0.38) | TRIM24TRIM33ALDH1A1CRBNCA1 | |
| SCHEMBL2046509 | 0.86 | TRIM24 (0.38) | TRIM24TRIM33ALDH1A1CRBNCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11840542-B2 | Method for producing cyclic enol ether compound | KAO CORPORATION (JP) | 2023-12-12 | — | — | US | disclosed |
| US-10668446-B2 | Flow-through reactors for the continuous quenching of peroxide mixtures and methods comprising the same | P2 SCIENCE, INC. (US) | 2020-06-02 | — | — | US | disclosed |
| US-10668446-B2 | Flow-through reactors for the continuous quenching of peroxide mixtures and methods comprising the same | P2 SCIENCE, INC. (US) | 2020-06-02 | — | — | US | disclosed |
| EP-3472124-A1 | FLOW-THROUGH REACTORS FOR THE CONTINUOUS QUENCHING OF PEROXIDE MIXTURES AND METHODS COMPRISING THE SAME | P2 Science, Inc. (US) | 2019-04-24 | — | — | EP | disclosed |
| US-20190091645-A1 | FLOW-THROUGH REACTORS FOR THE CONTINUOUS QUENCHING OF PEROXIDE MIXTURES AND METHODS COMPRISING THE SAME | P2 SCIENCE, INC. | 2019-03-28 | — | — | US | disclosed |
| US-20190091645-A1 | FLOW-THROUGH REACTORS FOR THE CONTINUOUS QUENCHING OF PEROXIDE MIXTURES AND METHODS COMPRISING THE SAME | P2 SCIENCE, INC. | 2019-03-28 | — | — | US | disclosed |
| WO-2017223220-A1 | FLOW-THROUGH REACTORS FOR THE CONTINUOUS QUENCHING OF PEROXIDE MIXTURES AND METHODS COMPRISING THE SAME | P2 SCIENCE, INC. (US) | 2017-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11840542-B2 | Method for producing cyclic enol ether compound | ERG28, ADH1A, SQLE | TRIM24 1205/4885TRIM33 3829/4885ALDH1A1 632/4885 |
| US-10668446-B2 | Flow-through reactors for the continuous quenching of peroxide mixtures and methods comprising the same | GPX4, NOX5, NOX4 | TRIM24 2770/4885TRIM33 1725/4885ALDH1A1 2884/4885 |
| US-20190091645-A1 | FLOW-THROUGH REACTORS FOR THE CONTINUOUS QUENCHING OF PEROXIDE MIXTURES AND METHODS COMPRISING THE SAME | GPX4, NOX5, NOX4 | TRIM24 2770/4885TRIM33 1725/4885ALDH1A1 2884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.